ARISE and ENCORE Studies for Patients with MAC Lung Disease

Purpose of Study:

To evaluate a potential treatment for MAC lung infection and its impact on symptoms including respiratory discomfort and fatigue.

Study Dates:
October 1, 2020 - May 31, 2022

Type of Study:
Pre-Market

Study Design:
Controlled Design

Study Location:
Nationwide

Funding Source:
Insmed Incorporated

Sponsors:

Insmed Incorporated

What is the identifier for this study on ClinicalTrials.gov?  

ARISE: https://clinicaltrials.gov/ct2/show/NCT04677543

ENCORE: https://www.clinicaltrials.gov/ct2/show/NCT04677569

 

Register for Trial
Freedom From Smoking Clinic
Detroit, MI | May 29, 2024
Asthma Basics Workshop - National
, | Jun 18, 2024